Subchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male rats
Abstract
Rivastigmine (RVT) is a reversible inhibitor of cholinesterase approved worldwide for the treatment of cognitive dysfunctions, especially in Alzheimer’s disease. Most previous pre-clinical studies have examined the effects of RVT treatment in a wide variety of pathological research models. Nonetheless, the effects of this drug on sensorimotor gating, memory, and learning tasks in healthy subjects remains unclear. In this study, we investigate...
Paper Details
Title
Subchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male rats
Published Date
Dec 1, 2019
Journal
Volume
376
Pages
112077 - 112077
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History